Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > It Was Just A Typo

<< Previous

Bullboard Posts

Next >>

Comment by itntdfon Jun 27, 2024 4:01pm

55 Views

Post# 36109576

RE:RE:It Was Just A Typo

notice for text errors, the filer MAY file a correction.

SEC staff generally does not correct errors in EDGAR filings, nor does staff typically intervene in the filing process.

Filers should be prepared to correct the following matters through corrective disclosure--in other words, by filing a correction or amendment to the incorrect filing, or, if applicable, withdrawing a duplicate filing:

To correct the submission type. If a filing is submitted using the wrong submission type, the filer should refile the document using the correct submission type. SEC staff generally will not delete the original filing from the EDGAR system.
To correct the file number. If a filing includes an incorrect file number, a filer may refile the document with the correct file number. SEC staff generally will not correct the information on the EDGAR system.
To correct other information in a filing. If a filing is made containing incorrect text, the filer may refile the document with the correct information. Staff will not make pre- or post-acceptance changes to the text of filings.